Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  rectal cancer, colon cancer
Trial Type:  Screening, Prevention
Results 1-12 of 12 for your search:
Start Over
Eflornithine and/or Sulindac in Preventing Recurrence of High-Risk Adenomas and Second Primary Disease in Patients with Stage 0-III Colon or Rectal Cancer
Status: Active
Phase: Phase III
Type: Prevention
Age: 18 and over
Trial IDs: S0820, NCI-2012-02067, SWOG-S0820, NCT01349881
A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Status: Active
Phase: Phase III
Type: Prevention
Age: 18 and over
Trial IDs: CR107047, NCI-2016-00410, 2015-001630-21, 39039039STM4001, NCT02555878
Biomarkers for Early Detection of Colorectal Cancer in Adults Undergoing Colonoscopy
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Screening
Age: 50 to 80
Trial IDs: GLNE 010, NCI-2012-00679, CDR0000703565, NCCTG-GLNE010, NCT01511653
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients with Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Status: Not yet active
Phase: Phase II
Type: Prevention
Age: 18 to 69
Trial IDs: MAY2016-07-01, NCI-2016-01674, N01-CN-2012-00042, NCT02961374
Aspirin in Preventing Colorectal Cancer in Patients with Colorectal Adenoma
Status: Not yet active
Phase: Phase II
Type: Prevention
Age: 18 and over
Trial IDs: NCI2015-06-01, NCI-2016-01642, N01-CN-2012-00035, NWU2015-06-01, NCT02965703
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients with Lynch Syndrome
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 2013-0698, NCI-2014-00046, 13-585, HHSN26100003; RFP B, HHSN261201200034I, HUM00079757, MDACC IRB # 2013-0698, N01-CN-2012-00034, NCT02048735, MDA2013-01-02, NCT02052908
Berberine Chloride in Preventing Colorectal Cancer in Patients with Ulcerative Colitis in Remission
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 70
Trial IDs: NCI 2014-03-01, NCI-2015-00173, NWU2014-03-01, NCT02365480
Universal Screening for Lynch Syndrome in Patients with Newly Diagnosed Colorectal Cancer or Endometrial Cancer and Their Relatives
Status: Active
Phase: No phase specified
Type: Genetics, Screening, Tissue collection/Repository
Age: 18 and over
Trial IDs: OSU-12170, NCI-2014-02303, 2012C0123, NCT01850654
Aspirin in Preventing Colorectal Cancer in Patients Who Have Undergone Colonoscopy and Adenoma Removal
Status: Active
Phase: No phase specified
Type: Prevention
Age: 18 to 80
Trial IDs: 14-496, NCI-2015-00626, NCT02394769
Tailored Navigation Intervention in Increasing Colorectal Cancer Screening among African Americans
Status: Active
Phase: No phase specified
Type: Screening
Age: 50 to 79
Trial IDs: 08G.89, NCI-2015-01435, 2008-02, OHR-8H, NCT00893295
Narratives in Promoting Colorectal Cancer Screening in Older Participants
Status: Active
Phase: No phase specified
Type: Behavioral study, Screening
Age: 50 to 75
Trial IDs: 201501019, NCI-2015-00798, NCT02485561
Physical Activity in Changing Gut Microbiota, Butyrate, and Inflammation in Individuals at High Risk for Colorectal Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 21 to 69
Trial IDs: AAAP1611, NCI-2015-01688, NCT02780284
Start Over